Hypertension in the Young. Preventing the Evolution of Disease Versus Prevention of Clinical Events**Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 50, Issue 9, 2007, Pages 840-842

  Williams, Bryan ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; EDITORIAL; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; PRIORITY JOURNAL; PULSE PRESSURE; STROKE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BLOOD VESSELS; DISEASE PROGRESSION; ELASTICITY; HUMANS; HYPERTENSION; STRESS, MECHANICAL;

EID: 34547944358     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.020     Document Type: Editorial

References (18)

1. Williams B. Recent hypertension trials: implications and controversies. J Am Coll Cardiol 45 (2005) 813-827
2. Williams B. Evolution of hypertensive disease. Lancet 368 (2006) 6-8
3. Korsgaard N., Aalkjaer C., Heagerty A.M., Izzard A.S., and Mulvany M.J. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 22 (1993) 523-526
4. Antonios T.F., Singer D.R., Markandu N.D., Mortimer P.S., and MacGregor G.A. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34 (1999) 655-658
5. Safar M.E., Levy B.I., and Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 107 (2003) 2864-2869
6. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
7. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., and Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114 (1991) 345-352
8. Mulvany M.J., and Aalkjaer C. Structure and function of small arteries. Physiol Rev 70 (1990) 921-971
9. Laurent S., Katsahian S., Fassot C., Tropeano A.I., Laloux B., and Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34 (2003) 1203-1206
10. Mattace-Raso F.U.S., van der Cammen T.J.M., Hofman A., et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 113 (2006) 657-663
11. Rizzoni D., Porteri E., Boari G.E., et al. Prognostic significance of small-artery structure in hypertension. Circulation 108 (2003) 2230-2235
12. Wong T.Y., Klein R., Sharrett A.R., et al. Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities study. JAMA 287 (2002) 1153-1159
13. Wong T.Y., Klein R., Couper D.J., et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 358 (2001) 1134-1140
14. Okin P.M., Devereux R.B., Jern S., et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292 (2004) 2343-2349
15. Duprez D.A., Florea N.D., Jones K., and Cohn J.N. Beneficial effects of valsartan in asymptomatic individuals with vascular or cardiac abnormalities: the DETECTIV pilot study. J Am Coll Cardiol 50 (2007) 835-839
16. Schiffrin E.L., Park J.B., Intengan H.D., and Touyz R.M. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101 (2000) 1653-1659
17. Park J.B., Ernesto L., and Schiffrin E.L. Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension. J Hypertens 19 (2001) 921-930
18. Julius S., Nesbitt S.D., Egan B.M., et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 354 (2006) 1685-1697